PMID- 32211780 OWN - NLM STAT- MEDLINE DCOM- 20210211 LR - 20210211 IS - 1462-0332 (Electronic) IS - 1462-0324 (Linking) VI - 59 IP - 11 DP - 2020 Nov 1 TI - Biomarker panels may be superior over single molecules in prediction of renal flares in systemic lupus erythematosus: an exploratory study. PG - 3193-3200 LID - 10.1093/rheumatology/keaa074 [doi] AB - OBJECTIVE: Recent evidence suggests that some urinary biomarkers, namely Vascular Cell Adhesion Molecule-1 (VCAM-1), Intercellular Adhesion Molecule-1 (ICAM-1), Monocyte Chemoattractant Protein 1 (MCP-1), Neutrophil Gelatinase Associated Lipocalcin and Lipocalin-type Prostaglandin D-Synthetase (L-PGDS), might discriminate SLE patients with ongoing renal activity from those with stable disease. The objective of this study was to assess the role of these markers in predicting renal flares in comparison with conventional biomarkers and to derive a biomarker panel which may improve diagnostic accuracy. METHODS: Eligible participants were SLE patients prospectively followed at our clinic. Urinary biomarker levels were measured in urinary sample by ELISA assay and were compared by the unpaired Student's t test or the Mann-Whitney U test as appropriate. Receiver operating characteristic analysis was used to calculate the area under the curve. Cox regression was used to identify independent factors associated with disease flares. RESULTS: Urine was collected from 61 patients. During 8 months' follow-up, eight patients experienced a renal flare. Urinary L-PGDS, ICAM-1 and VCAM-1 levels were significantly increased in the patients who subsequently experienced a renal flare with respect to the remaining 53. At Cox regression analysis, L-PGDS, ICAM-1, VCAM-1, hypocomplementemia and anti-dsDNA antibodies were factors associated with renal flares. Based on receiver operating characteristic analysis, a combination of novel and conventional biomarkers demonstrated an excellent ability for accurately identifying a flare. CONCLUSION: This study might suggest the usefulness of a novel biomarker panel in predicting a renal flare in SLE. CI - (c) The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com. FAU - Fasano, Serena AU - Fasano S AD - Rheumatology Section, Department of Precision Medicine, University of Campania L. Vanvitelli, Naples, Italy. FAU - Pierro, Luciana AU - Pierro L AD - Rheumatology Section, Department of Precision Medicine, University of Campania L. Vanvitelli, Naples, Italy. FAU - Borgia, Alessia AU - Borgia A AD - Rheumatology Section, Department of Precision Medicine, University of Campania L. Vanvitelli, Naples, Italy. FAU - Coscia, Melania Alessia AU - Coscia MA AD - Rheumatology Section, Department of Precision Medicine, University of Campania L. Vanvitelli, Naples, Italy. FAU - Formica, Ranieri AU - Formica R AD - Rheumatology Section, Department of Precision Medicine, University of Campania L. Vanvitelli, Naples, Italy. FAU - Bucci, Laura AU - Bucci L AD - Rheumatology Section, Department of Precision Medicine, University of Campania L. Vanvitelli, Naples, Italy. FAU - Riccardi, Antonella AU - Riccardi A AD - Rheumatology Section, Department of Precision Medicine, University of Campania L. Vanvitelli, Naples, Italy. FAU - Ciccia, Francesco AU - Ciccia F AD - Rheumatology Section, Department of Precision Medicine, University of Campania L. Vanvitelli, Naples, Italy. LA - eng PT - Comparative Study PT - Journal Article PL - England TA - Rheumatology (Oxford) JT - Rheumatology (Oxford, England) JID - 100883501 RN - 0 (Biomarkers) SB - IM MH - Adult MH - Biomarkers/urine MH - Female MH - Humans MH - Kidney Diseases/*etiology/*urine MH - Lupus Erythematosus, Systemic/*complications/*urine MH - Male MH - Middle Aged MH - Predictive Value of Tests MH - Prospective Studies OTO - NOTNLM OT - biomarkers OT - lupus nephritis OT - systemic lupus erythematosus EDAT- 2020/03/27 06:00 MHDA- 2021/02/12 06:00 CRDT- 2020/03/27 06:00 PHST- 2019/09/24 00:00 [received] PHST- 2020/01/27 00:00 [revised] PHST- 2020/03/27 06:00 [pubmed] PHST- 2021/02/12 06:00 [medline] PHST- 2020/03/27 06:00 [entrez] AID - 5811390 [pii] AID - 10.1093/rheumatology/keaa074 [doi] PST - ppublish SO - Rheumatology (Oxford). 2020 Nov 1;59(11):3193-3200. doi: 10.1093/rheumatology/keaa074.